BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer. We currently market an internally discovered product in the United States and Canada, BRUKINSA® (zanubrutinib). To learn more visit www.brukinsa.com
Contact:
E-mail - lori.mackin@beigene.com
Featured Content
